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Abstract
Upon encounter with antigen, CD41 T cells differentiate into effector Th subsets with distinctive
functions that are related to their unique cytokine profiles and anatomical locations. One of the most
important Th functions is to provide signals to developing B cells that induce specific and appropriate
antibody responses. The major CD41 T cell subset that helps B cells is the T follicular helper (TFH) cell,
whose expression of the chemokine receptor CXCR5 [chemokine (C–X–C motif) receptor 5] serves to
localize this cell to developing germinal centers (GCs) where it provides instructive signals leading to
Ig class switching and somatic mutation. TFH cells produce high levels of IL-21, a cytokine that is
critical for GC formation and also for the generation of TFH cells. Although TFH cells have been found
to produce cytokines characteristic of other Th subsets, they represent a distinct lineage whose
development is driven by the transcription factor B-cell CLL lymphoma-6 (BCL6). Consistent with
their critical role in the generation of antibody responses, dysregulated TFH function has been
associated with the development of systemic autoimmunity. Here, we review the role of IL-21 in the
regulation of normal TFH development and function as well as in progression of autoimmune
responses.
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Introduction
Specific CD4+ T cell effector responses can be delegated
to distinct subsets characterized as Th1, Th2, Th17 or regu-
latory T cell (Treg) cells, with the development of each of
these subsets being driven, respectively, by the master
lineage-specific transcription factors T-bet [now also denoted
as T-box 21 (TBX21)], GATA binding protein 3 (GATA-3), reti-
noid-related orphan receptor ct (RORct) or forkhead box
protein P3 (FOXP3) (1). T-cell-dependent antibody production
is a critical component of the normal immune response, and
Th2 cells were originally believed to be the predominant
source of B cell help because of their production of IL-4, a
cytokine known to be involved in B cell proliferation as well
as Ig class switching (1).
Subsequently, IL-21 was identified as a Th-derived, type I,
four-a-helical bundle cytokine that was critical for plasma cell
generation as well as isotype switching (2) and normal Ig
production (3), consistent with IL-21 being a Th2-specific cy-
tokine (4); however, other data indicated that IL-21 had Th1-
like properties as well (5).
More recently it became clear that the CD4+ T cells involved
in germinal center (GC) formation and function—denoted
T follicular helper cells (TFH cells)—were distinct from any
of these previously identified subsets. These TFH cells
expressed high levels of the chemokine receptor CXCR5
[chemokine (C–X–C motif) receptor 5], allowing them to home
to and be retained by the lymphoid follicle, where contact with
antigen-primed B cells led to B cell proliferation, isotype
switching and somatic mutation of the Ig repertoire (6, 7).
Gene microarray analysis revealed that follicle-localized
CXCR5+ Th cells had a very distinctive transcriptional profile
that distinguished these cells from Th1 or Th2 cells, with high-
level IL-21 and B-cell CLL lymphoma-6 (BCL6) messenger
RNAs (mRNAs) (5), both of which are now considered hall-
marks of TFH cells (6).
IL-21 is a type I cytokine that signals via a specific re-
ceptor protein, IL-21R (8, 9), and the common cytokine
receptor c chain, cc, which is shared by the receptors for
IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21 (10); cc is mutated in
humans with X-linked SCID (11). IL-21 signals in part via
STAT3 (signal transducer and activator of transcription 3)
(12), with actions on a wide range of lineages, including
T cells, B cells, NK cells and dendritic cells (10). Specifically,
IL-21 can promote the expansion of CD8+ T cells, is critical
for normal Ig production by B cells, can inhibit dendritic cell
function and, interestingly, can be pro-apoptotic for B cells
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as T-box 21 (TBX21)], GAT binding protein 3 (GAT -3), reti-
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Th2 cells wer originally beli v d to be the predomina t
source of B cell help because of their production of IL-4, a
cytokine known to be involved in B cell proliferation as well
as Ig class witching (1).
Subsequently, IL-21 was identified as a Th-derived, type I,
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production (3), consistent with IL-21 being a Th2-specific y-
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ceptor protein, IL-21R (8, 9), and the com on cytokine
receptor c hain, cc, which is hared by the rec ptors for
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humans with X-linked SCID (11). IL-21 signals in part via
STA 3 (signal transducer and activator of transcription 3)
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for normal Ig production by B cells, can inhibit dendritic ell
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Abstract
Myeloid and non-myeloid cells express members of the C-type lectin-like receptor (CTLR) family, 
hich mediate crucial cellular functions during immunity and homeostasis. Of relevance here 
is the dendritic cell-associated C-type lectin-2 (Dectin-2) family of CTLRs, which includes blood 
dendritic cell a tigen 2 (BDCA-2), dendritic cell immunoactivating receptor (DCAR), dendritic 
cell immunoreceptor (DCIR), Dectin-2, C-type lectin superfamily 8 (CLECSF8) and macrophage-
inducible C-type lectin (Mincle). These CTLRs possess a single extracellular conserved C-type 
lectin-like domain and are capable of mediating intracellular signalling either directly, through 
integral signalling domai s, or i directly, y associating with signalling adaptor molecul s. 
The e rec ptors r cognize a diverse range of end genous and exog nous ligands, and can 
function as pattern recognition receptors for sever l classe  of pathog ns i cluding fungi, 
bacteria and parasites, driving both innate and adaptive immunity. In this review, we summarize 
our knowledge of each of these receptors, highlighting the exciting discoveries that have been 
made in recent years.
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Introduction
C-type lectin-like receptors (CTLRs) constitute a group of over 
1000 receptors found in either membrane bound or soluble 
forms (1). These receptors are characterized by the pres-
ence of at least one carbohydrate recognition domain (CRD), 
or in the broader sense, a C-type lectin-like domain (CTLD), 
which are formed by disulphide bonds between highly con-
served cysteine residues (1). Initially named ‘C-type’ due to 
their requirement for Ca2+ to bind carbohydrates, it was sub-
sequently discovered that not all CTLRs are Ca2+ dependent 
and that these receptors can recognize a more diverse range 
of ligands. CTLRs are often also multivalent (able to bind dif-
ferent classes of ligands) and recognize both exogenous 
and endogenous ligands. Importantly, many of these recep-
tors can mediate cellular responses by triggering intracellular 
signalling pathways either directly, through integral signalling 
domains, or indirectly, by associating with signalling adaptor 
molecules.
Here, we focus on the dendritic cell-associated C-type 
lectin-2 (Dectin-2) family of CTLRs, which comprises blood 
dendritic cell antigen 2 (BDCA-2), dendritic cell immuno-
activating receptor (DCAR), dendritic cell immunoreceptor 
(DCIR), Dectin-2, C-type lectin superfamily 8 (CLECSF8) 
and macrophage-inducible C-type lectin (Mincle) (2) 
(Fig. 1). The genes encoding these receptors are grouped 
on the telomeric region of the NK gene cluster on mouse 
chromosome 6 and on human chromosome 12. These 
CTLRs are type II transmembrane receptors possessing a 
single extracellular conserved CTLD and all members of 
this family have short cytoplasmic tails and induce intracel-
lular signalling indirectly, except for DCIR that has a longer 
cytoplasmic tail containing an integral inhibitory signalling 
motif. In this review, we provide an update on each of these 
CTLRs (2), focusing on the most recent and exciting dis-
coveries relating to their expression, ligands, signalling and 
physiological roles.
Blood dendritic cell antigen 2
BDCA-2 is widely accepted as a highly specific marker 
for human plasmacytoid dendritic cells (pDCs), although 
a murine homologue has not been defined (3). Lacking 
signalling motifs in its cytoplasmic tail, human BDCA-2 
(hBDCA-2) associates through its transmembrane domain 
with the immunoreceptor tyrosine-based activation motif 
ti l I l , l  5   5  . 27 277













(ITAM)-containing signalling adaptor, FcRγ, and can induce 
intracellular signal transduction in a B-cell receptor (BCR)-
like fashion employing Syk and other downstream signalling 
molecules (4–6) (Fig. 1). Importantly, unlike many other ITAM-
coupled receptors, signalling through BDCA-2 does not lead 
to activation of the nuclear factor (NF)-κB pathway. In fact, 
Fig. 1. The Dectin-2 cluster of C-type lectins. The Dectin-2 family of C-type lectin receptors are encoded at the telomeric end of the NK gene 
cluster on human chromosome 12 (A) and mouse chromosome 6 (B). (C) Schematic representation of signal transduction pathways induced 
by the various Dectin-2 family CTLRs. BLNK, B-cell linker protein; BTK, Bruton’s tyrosine kinase; TM, transmembrane.












cross-linking of BDCA-2 on pDCs inhibits activation of the 
NF-κB pathway and the production of type I interferons and 
other cytokines, notably in response to TLR9 ligands (4–6) 
(Table  1). More recently, BDCA-2 signalling has also been 
shown to inhibit the pDC secretion of tumour necrosis factor 
(TNF)-related apoptosis-inducing ligand (TRAIL) (7).
Triggering of BDCA-2, like the BCR, induces phosphoryla-
tion of many cytoskeletal proteins, including actin, tubulin 
and the clathrin heavy chain, resulting in internalization of 
the receptor; a process that may also involve the EEE (late 
endosomal sorting) motif in the cytoplasmic tail of BDCA-2 
(5, 6, 8). Targeting of BDCA-2 using antibodies was shown to 
lead to internalization of the antibody complexes and pres-
entation to T cells, suggesting a possible role for this recep-
tor in antigen capture and presentation (5). However, more 
recent evidence has demonstrated that BDCA-2 signalling 
actually inhibits antigen processing and presentation to T 
cells by pDCs (9, 10). BDCA-2 cross-linking also suppressed 
the expression of co-stimulatory molecules, including CD40 
and CD86, on pDCs matured with the TLR9 ligand, CpG (9, 
10). However, this did not occur during CD40 ligand-medi-
ated pDC maturation, indicating specificity in the effects of 
BDCA-2 stimulation (9).
BDCA-2 contains an EPN motif in its CTLD, which would 
suggest that the receptor recognizes mannose-based ligands 
(8). However, such ligands have not been conclusively iden-
tified (11) and BDCA-2 was recently shown to recognize 
asialo-galactosyl-oligosaccharides with terminal β1–4- and 
β1–3-galactose residues (12). Indeed, through recognition of 
these carbohydrates, BDCA-2 was capable of binding cer-
tain CD14+ monocytes, monocyte-derived DCs, as well as 
several tumour cell lines (12). Importantly, co-culture experi-
ments demonstrated that expression of these ligands corre-
lated with the suppression of type I  interferon secretion by 
pDCs (12). BDCA-2 has also been shown to bind the HIV-1 
envelope glycoprotein gp120 (13) and very recently, the hep-
atitis C virus (HCV) glycoprotein E2 (14), both of which can 
inhibit interferon production by pDCs.
Dendritic cell immunoactivating receptor
Little is known about DCAR and DCAR1, both of which are 
not found in humans (15, 16). Murine DCAR (mDCAR) tran-
scripts were detected in bone marrow-derived DCs, lung, 
spleen and at low levels in skin and lymph node tissue (15). In 
contrast, mDCAR1 expression (protein) was tissue depend-
ent and restricted to CD8+ DCs in spleen and thymus, and to 
subpopulations of CD11b+ myeloid cell populations in spleen 
and bone marrow. However, DCAR1 was not detected in 
peripheral blood or lymph nodes (16).
Both receptors appear to be able to induce intracellular 
signalling, but only DCAR has been formally demonstrated 
to associate with the FcRγ chain, in part through associa-
tion with an arginine residue in the transmembrane region of 
the CTLR (15, 16) (Fig.  1). Antibody-mediated targeting of 
model antigens to DCAR1 on primary cells resulted in endo-
cytosis, trafficking to lysosomal compartments and efficient 
induction of humoral, CD8+ and CD4+ T-cell responses (16). 
Furthermore, DCAR1 signalling was able to modulate DC 
functions, enhancing IL-12 production and down-regulating 
IL-10 secretion (16) (Table 1). In summary, current data sug-
gest that DCAR and DCAR1 may be activating receptors, but 
the ligands and physiological roles of these CTLRs remain 
unknown.
Dendritic cell immunoreceptor
Humans possess only a single gene encoding human DCIR 
(hDCIR), whereas mice encode four DCIR-like proteins 
(designated mDCIR1–4) (17, 18) (Fig.  1 and Table  1). 
The hDCIR is expressed by all CD14+ monocytes, CD15+ 
granulocytes, all DC subsets (including pDCs) and B cells in 
peripheral blood (18–21). Although originally not thought to 
be expressed on NK or T cells (18), recent evidence suggests 
that DCIR expression can be induced on CD4+ T cells 
following their infection with HIV and also by soluble factors 
released from HIV-infected cells (22). In mice, the expression 
of mDCIR1 shows similarity with the human receptor (23), 
Table 1. C-type lectin receptor ligands and signallinga
Receptor Alternative names Ligands Cellular effect upon triggering
hBDCA-2 CLEC4C, CLECSF7, HECL, DLEC,  
CD303, CLECSF1, CLECSF11
HIV-1 gp120; asialo-galactosyl-oligosac-
charides with terminal β1–3- and β1–4-
galactose; HCV E2
↓IFN; ↓TNF; ↓IL-6; ↑IL-10; 
↑Ca2+ influx
mDCAR, mDCAR1 CLEC4b1, CLEC4b2 Unknown ↓IL-10; ↑IL-12
hDCIR, mDCIR1–4 hCLEC4A, hCLECSF6,  
mCLEC4a1–4
HIV-1 (gp120); HCV (E2); unknown ↓IFN; ↓TNF; ↓IL-12; ↓Ca2+ 
influx; ↓Protein tyrosine 
phosphorylation; ↓DC 
expansion; cross-presentation
mDECTIN-2 CLEC4n α-mannans; M. tuberculosis; house dust 
mite; Fungi (e.g. Candida); CD4+ CD25+ 
T-cell ligand
↑TNF; ↑IL-1; ↑IL-6; ↑IL-23; 
↑Cysteinyl leukotrienes; 
↑ROS; ↑NALP3 activation; 
↑IL-4; ↑IL-10; ↑eicosanoids; 
phagocytosis
hCLECSF8 CLEC4D, mMCL, CLEC6 Unknown ↑TNF; ↑ROS; phagocytosis
mMINCLE CLECSF9, CLEC4e Mycobacteria; Candida; Malassezia; 
Fonsecaea; SAP130 (dead cells)
↑TNF; ↑MIP-2; ↑KC; ↑IL-10; 
↑IL-6; ↑CXCL1/2; ↑NALP3 
activation; respiratory burst
aSee text for references.












whereas mDCIR2 appears to be a specific marker for CD8– 
DCs located in the red pulp and marginal zone of the mouse 
spleen (24). The expression patterns of the other murine 
receptors are still unclear, although mRNA analysis suggests 
that they are expressed on DCs and macrophages (17).
Unlike the other Dectin-2 family members, the DCIR proteins 
have long cytoplasmic tails, which, in hDCIR and mDCIR1 
and mDCIR2, contain classical immunoreceptor tyrosine-
based inhibitory signalling motifs (ITIMs) (17). Although the 
cytoplasmic domains of murine DCIR3 and DCIR4 lack con-
sensus ITIMs, they possess conserved tyrosine residues, 
which is suggestive of an ability to transduce intracellular 
signals. The ITIMs of both hDCIR and mDCIR1 have been 
shown to mediate inhibitory signalling through activation of 
the phosphatases SHP-1 and SHP-2 (19, 23, 25, 26).
Activation of hDCIR on DCs or pDCs, e.g. by antibodies 
or HCV (see below) resulted in specific inhibition of TLR8-
mediated IL-12 and TNF production, and TLR9-induced IFN-
α production, respectively (14, 19, 20) (Table 1). In addition, 
targeting of this receptor with antibodies was found to cause 
clathrin-dependent receptor internalization, trafficking to 
lysosomal compartments, and antigen presentation (19, 20). 
Targeting of hDCIR was also found to efficiently drive antigen 
cross-presentation in DCs and activate CD8+ T cells (21). In 
mice, however, targeting of mDCIR2 was found to favour MHC 
class II presentation and CD4+ T-cell activation (24), as well 
as stimulation of natural FoxP3+ T regulatory cells (27). More 
recently, targeting of mDCIR2 was found to initiate extrafol-
licular B-cell responses to T-cell-dependent antigens (28).
The CTLD of DCIR possesses conserved features, includ-
ing an EPS motif, suggesting that it is able to recognize car-
bohydrates (18). Although there is some evidence that this 
receptor can recognize fucose and mannose (11), definitive 
carbohydrate ligands have not been defined. However, DCIR 
has been identified as an attachment factor for HIV on DCs 
(29) and more recently for HCV (through glycoprotein E2) on 
pDCs (14). DCIR-mediated binding of HIV promoted infec-
tion of CD4+ T cells, and enhanced DCIR expression and HIV 
replication in these cells (22, 29); a process that required the 
neck region of DCIR and ITIM-mediated signal transduction 
from the receptor (26).
DCIR has also been implicated in autoimmunity. In mice, 
deficiency of mDCIR2 resulted in the spontaneous devel-
opment of sialadenitis and enthesitis, and exacerbated 
responses to collagen-induced arthritis, effects that were 
attributed to unrestricted DC expansion (30). Moreover, in 
humans, polymorphisms of DCIR have been associated with 
susceptibility to rheumatoid arthritis and the receptor was 
found to be abundantly expressed in affected joints (31–33). 
However, the endogenous ligand(s) of DCIR involved in these 
functions are not yet defined.
Dendritic cell-associated C-type lectin-2
Dectin-2 was originally identified as a Langerhans cell-spe-
cific CTLR, but was subsequently shown to be expressed 
on a variety of myeloid cells, including tissue macrophages, 
neutrophils and several DC subsets (including pDCs) (34–
38). Dectin-2 is also expressed at low levels on peripheral 
blood monocytes, although its expression on these cells can 
be greatly up-regulated by inflammatory stimuli (35). Human 
Dectin-2 has been detected on DCs and monocytes, and 
mRNA analysis suggests that it may also be expressed by 
lymphocytes (39, 40).
Like other activation CTLRs in this family, Dectin-2 has 
a short cytoplasmic tail and associates with the FcRγ. 
Interestingly, this interaction is not mediated by the trans-
membrane arginine residue of Dectin-2, but rather by a 
membrane-proximal part of its short cytoplasmic tail (41) 
(Fig.  1). Signalling from Dectin-2 is mediated through the 
Syk, PKCδ and CARD9–Bcl10–Malt1 (caspase recruitment 
domain 9–B-cell lymphoma 10–mucosa-associated lymphoid 
tissue lymphoma translocation gene 1) pathway, leading to 
the induction of several cytokines and chemokines (includ-
ing TNF, IL-2, IL-10, IL-23, IL-1β, IL-6 and IL-12) (36, 41–44) 
(Table 1). More recently, Dectin-2 signalling has been shown 
to involve phospholipase Cγ2 and mitogen-activated protein 
kinases (MAPKs) (45) and to selectively activate the c-Rel 
NF-κB subunit, via Malt1, driving the production of Th17-
polarizing cytokines (IL-23, IL-1β) (39). Triggering of Dectin-2 
also induces the respiratory burst (45, 46), nucleotide-bind-
ing oligomerization domain-like receptor containing pyrin 
domains 3 (Nlrp3) inflammasome activation (46) and the pro-
duction of several eicosanoids, some of which were found to 
promote Th2 immunity (47–49).
Dectin-2 contains a ‘classical’ CTLD containing a man-
nose-binding EPN motif, which binds structures with high 
mannose content (50), and much attention has been focused 
on its role as a pathogen recognition receptor (PRR). Indeed, 
Dectin-2 is capable of recognizing numerous pathogens, 
including Candida albicans, Saccharomyces cerevisiae, 
Mycobacterium tuberculosis, Paracoccidioides brasiliensis, 
Histoplasma capsulatum, Aspergillus fumigatus, non-encap-
sulated Cryptococcus neoformans, Microsporum audouinii, 
Trichophyton rubrum, Schistosoma mansoni and house dust 
mite allergens (41, 46, 47, 50).
The best-studied interaction is with C. albicans, an organ-
ism for which Dectin-2 function was found to be essential for 
protective host immunity (36, 43). Indeed, during infection 
with C.  albicans, Dectin-2 was shown to drive host inflam-
matory cytokine responses and the development of adap-
tive immunity (particularly Th17 and Th1 responses), and 
mice lacking this receptor demonstrated greatly increased 
susceptibility (increased fungal burdens and rapid death). 
Notably, the functions of this CTLR appear to differ between 
the yeast and hyphal forms of C. albicans, possibly due to 
exposure of different ligands, suggesting that this PRR can 
distinguish between the different morphological forms of this 
pathogen (41–43). Interestingly, Dectin-2 has also been impli-
cated in UV-induced immunosuppression through recogni-
tion of an endogenous ligand, but the identity of this molecule 
is unknown (51).
C-type lectin superfamily 8
CLECSF8 is another poorly studied CTLR in the Dectin-2 
cluster and is found in both mice and humans (Fig.  1). It 
was originally isolated from mice as a macrophage-specific 
receptor (52), but recent human protein expression data 
have shown that it is more widely expressed on peripheral 












blood neutrophils, CD14+CD16– classical monocytes and 
weakly by several DC subsets (53). In contrast to other 
members of the Dectin-2 cluster, the CTLD of CLECSF8 
lacks conserved amino acids normally associated with 
carbohydrate recognition, consistent with a failure to detect 
sugar ligands for this receptor using oligosaccharide 
microarrays (53).
Described previously as an endocytic receptor (54), 
recent studies have demonstrated that CLECSF8 can trig-
ger intracellular signalling through the kinase Syk, inducing 
phagocytosis, the respiratory burst and pro-inflammatory 
cytokine (TNF) production (53) (Table 1). Interestingly, sur-
face expression of CLECSF8 appeared to require a novel 
adaptor protein expressed in myeloid cells, as it did not 
associate with FcRγ, DNAX-activating protein of 10 kDa 
(DAP10) or DAP12 (53). This observation was consistent 
with the lack of charged amino acid residues in the trans-
membrane and cytoplasmic domains of CLECSF8 (52) that 
are normally required for such associations. Unusually, 
the association with the unidentified adaptor appeared to 
require the CTLD of CLECSF8 (53).
CLECSF8–/– mice have been generated and although dis-
playing slight, but not significant, differences in T- and B-cell 
phenotypes (2), these mice were found to have normal 
responses to necrotic cell death, sterile peritontis, the devel-
opment of spontaneous autoimmune arthritis and experimen-
tal autoimmune uveoretinitis (53). Moreover, these mice had 
no defects in their ability to resist infections with C. albicans, 
Nippostrongylus brasiliensis, Staphylococcus aureus and 
Listeria monocytogenes (53). Thus, CLECSF8 appears to 
function as an activation receptor, but its ligands and physi-
ological role remain to be defined.
Macrophage-inducible C-type lectin
As its name suggests, Mincle was discovered because it is 
strongly induced in macrophages by inflammatory stimuli, 
including LPS, TNF, IL-6 and IFN-γ (55). Found in both humans 
and rodents, Mincle is expressed on several cell types includ-
ing monocytes, macrophages, neutrophils, myeloid DCs and 
some subsets of B cells (17, 56–60). T cells, pDCs and NK 
cells do not express the receptor (56). Interestingly, Mincle 
appears to have a reciprocal expression pattern on neutro-
phils and monocytes in individual humans, which has func-
tional implications (see below) (56).
Like the other activating receptors in the Dectin-2 clus-
ter, Mincle associates with the FcRγ to transduce intracellu-
lar signalling (58) (Fig.  1). This association is mediated by 
a positively charged arginine residue in the transmembrane 
domain of this CTLR (58). Triggering of Mincle–FcRγ induces 
intracellular signalling through Syk, PKCδ, CARD9–Bcl10–
Malt1 and MAPK pathways resulting in the induction of sev-
eral cytokines and chemokines, including TNF, macrophage 
inflammatory protein 2 (MIP-2; CXCL2), keratinocyte-derived 
chemokine (KC; CXCL1) and IL-6 (44, 58) (Table 1). Although 
Mincle-mediated cellular responses are MyD88 independent, 
recent evidence demonstrates that Mincle and the TLRs can 
collaborate to synergistically induce inflammatory cytokine 
production, the respiratory burst and up-regulation of com-
plement receptor 3 (CR3) (59, 61).
Mincle possesses a classical CTLD domain containing 
an EPN motif and is capable of recognizing several types of 
carbohydrates, particularly those containing α-mannose (11, 
62). Notably, fungal, mycobacterial and necrotic cell ligands 
for Mincle have been identified, implicating this receptor in 
anti-microbial immunity and homeostasis. Indeed, a cell 
wall component of C. albicans was one of the first ligands 
described, and Mincle has been shown to drive protective 
immunity (inflammatory cytokine responses, fungal killing and 
phagocytosis) to this pathogen (56, 63).
Interestingly, in human monocytes, expression of Mincle 
was required for inflammatory cytokine responses, but 
inversely correlated with fungal uptake and killing, whereas 
in neutrophils, Mincle expression was associated with pro-
motion of the latter functions (56). Mincle also recognizes 
Fonsecaea pedrosoi, the causative agent of chromoblasto-
mycosis (61) and recent data demonstrate that this infection 
stems from insufficient TLR co-stimulation of CTLR responses 
(61). Importantly, these infections could be resolved by 
stimulating protective inflammatory responses through the 
administration of exogenous TLR ligands (61). Mincle also 
recognizes Malassezia and was required for the induction of 
several cytokines, chemokines and inflammatory cell recruit-
ment during infections in vivo (62).
In addition to fungi, Mincle recognizes trehalose dimyco-
late (TDM; also called mycobacterial cord factor), an immu-
nostimulatory glycolipid component that is of considerable 
interest for its role in anti-mycobacterial immunity and as 
an adjuvant for driving cell-mediated immune responses 
(64, 65). Indeed, Mincle and the FcRγ chain were found to 
mediate all the responses induced by TDM and its synthetic 
analogue trehalose dibehenate, including the production of 
inflammatory cytokines, nitric oxide, NLRP3 inflammasome 
activation, granuloma formation, and Th1 and Th17 adjuvan-
ticity (59, 60, 64–66).
In vitro studies have suggested that Mincle plays some role 
in driving these responses to intact mycobacteria (64, 65, 
67), but the in vivo role of Mincle is contradictory, possibly 
because of the use of different mycobacteria. Experiments 
using e.g. Mycobacterium bovis BCG or M.  tuberculosis 
Erdman, have suggested a protective role for this CTLR, as 
shown by altered inflammatory responses and increased 
bacterial burdens in the knockout animals (59, 68). In con-
trast, these parameters were unaltered in mice infected with 
M.  tuberculosis H37Rv (67). Interestingly, Mincle deficiency 
did not affect M.  tuberculosis-induced granuloma formation 
in either study (59, 67).
Mincle can also sense necrotic cell death, driving inflam-
matory responses (TNF and MIP-2) that result in neutrophil 
accumulation in the damaged tissues (58). Spliceosome-
associated protein (SAP)130 was identified as the endoge-
nous ligand that was recognized by Mincle following necrotic 
cell death (58). Interestingly, this interaction appeared to 
involve a binding site on Mincle that was different to that 
involved in its ability to recognize carbohydrates (58). The 
ability to recognize necrotic cells suggests that Mincle may 
be involved in autoimmunity, and although not been formally 
demonstrated in Mincle-deficient mice, a polymorphism in 
this receptor has recently been linked with protection against 
rheumatoid arthritis in men (69).













The last few years have provided exciting new insights into the 
functions of the ‘Dectin-2 cluster’ of CTLRs. These receptors 
recognize numerous pathogens and pathogen-derived 
products, trigger intracellular signalling cascades that have 
profound effects on cellular and immunological processes 
and play critical roles in anti-microbial immunity. Moreover, 
similar processes are triggered following the recognition of 
endogenous ligands, and these receptors have important 
functions in maintaining homeostasis and in the development 
of autoimmunity. Given the diverse and crucial roles of these 
CTLRs, it is perhaps surprising that we still know relatively little 
about their physiological functions. However, the burgeoning 
interest in this area will undoubtedly lead to a rapid increase 
in our knowledge in the coming years.
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